Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Chocoladefabriken Lindt & Sprüngli AG (LDSVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
10,900.000.00 (0.00%)
At close: 09:44AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close10,900.00
Open10,924.80
Bid0.00 x 0
Ask0.00 x 0
Day's Range10,900.00 - 10,900.00
52 Week Range9,150.00 - 13,875.50
Volume2
Avg. Volume37
Market Cap25.418B
Beta (5Y Monthly)0.28
PE Ratio (TTM)48.18
EPS (TTM)226.23
Earnings DateN/A
Forward Dividend & Yield123.28 (1.13%)
Ex-Dividend DateMay 02, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LDSVF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CHOCOLADEFABRIKEN LINDT SPRUNGL
    Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
    Rating
    Fair Value
    Economic Moat
    3 months agoMorningstar
View more
  • Financial Times

    Lindt: Swiss chocolatier counts on ‘lipstick effect’ to weather downturn

    Lindt & Sprüngli offered a sweet treat during the pandemic. The Swiss chocolate maker’s shares rose strongly in 2021, hitting a sugar high at the start of this year. Organic sales growth in the first half of 2022 exceeded 12 per cent. Earnings before interest and tax were up by more than a third.

  • Barrons.com

    Chocolate Maker Lindt Needs These Ingredients to Lift the Stock

    A sharp fall has created a buying opportunity in shares of the Swiss confectioner, which has gained market share in the U.S. and some other lands.

  • Reuters

    Chocolate-maker Lindt sees slower growth after bottlenecks bite

    ZURICH (Reuters) -Swiss chocolate maker Lindt & Spruengli expects sales of its upmarket chocolates to grow less in 2022 than last year, it said on Tuesday, and blamed supply chain bottlenecks for a slowdown in late 2021 in North America. The maker of the best-selling Lindor chocolate balls, which has maintained spending on advertising and new products throughout the COVID-19 pandemic, said market share gains boosted organic sales by 13.3% last year. Lindt, along with other chocolate makers, saw a dip in demand in 2020, but sales recovered strongly in 2021 as people ate more treats and bought gifts for friends and relatives they had been unable to see at the height of the pandemic.

Advertisement
Advertisement